Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News -- Ignore unavailable to you. Want to Upgrade?

To: tom pope who wrote (6325)	8/27/2008 6:17:35 PM
From: B O Trust	Read Replies (2) \| Respond to of 7143

Insulin-Free Diabetes Treatment possible and hopefully already by 2020-2025 as we alla know science will take some time from test in mice until reaching the market. The better for recent TYPE 1 and LADA patients swedish Diamyd Medical is close to market (by 2011) with a working vaccine with no side effects at all as no safety concerns have been reported in any clinical study with Diamyd. Their Phase III will begin soon both in the US and in EU. This vaccine shows significant effect preventing the autoimmune disease killing beta cells responsible for our insulin production. Diamyd company and share still unknown to the US market, yet. diamyd.com diamyd.com